Primecap Management CO Bio N Tech Se Transaction History
Primecap Management CO
- $127 Billion
- Q4 2024
A detailed history of Primecap Management CO transactions in Bio N Tech Se stock. As of the latest transaction made, Primecap Management CO holds 4,295,817 shares of BNTX stock, worth $413 Million. This represents 0.39% of its overall portfolio holdings.
Number of Shares
4,295,817
Previous 4,516,518
4.89%
Holding current value
$413 Million
Previous $536 Million
8.75%
% of portfolio
0.39%
Previous 0.4%
Shares
21 transactions
Others Institutions Holding BNTX
# of Institutions
364Shares Held
39.6MCall Options Held
3.01MPut Options Held
2.01M-
Baillie Gifford & CO8.22MShares$791 Million0.74% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.41MShares$424 Million2.03% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$182 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$174 Million1.03% of portfolio
-
Capital International Investors Los Angeles, CA1.42MShares$136 Million0.03% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $23.4B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...